<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-title>Mediators of Inflammation</journal-title><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18475602</article-id><article-id pub-id-type="pmc">2365597</article-id>
		<article-id pub-id-type="pii">S0962935194000736</article-id>
		<article-id pub-id-type="doi">10.1155/S0962935194000736</article-id>
	<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The Effect of Cromolyn Sodium and Nedocromil Sodium Administered by A pressurized Aerosol with A spacer
Device on Exercise-Induced Asthma in Children</article-title></title-group><contrib-group>
		<contrib contrib-type="author" corresp="yes"><name><surname>de Benedictis</surname><given-names>F. M.</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Tuteri</surname><given-names>G.</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Niccoli</surname><given-names>A.</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Mezzetti</surname><given-names>D.</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Rossi</surname><given-names>L.</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Bruni</surname><given-names>L.</given-names></name></contrib>
	</contrib-group>
		<aff id="aff1"><label>1</label>
			<addr-line>Clinica Pediatrica</addr-line>
			<addr-line>Policlinico Monteluce</addr-line>
			<addr-line>Universit&#x000e0; di Perugia</addr-line>
			<addr-line>Perugia</addr-line>
			<addr-line>06100</addr-line>
			<country>Italy</country>
		</aff>
	<pub-date pub-type="ppub"><year>1994</year></pub-date><volume>3</volume><issue>7</issue><fpage>S35</fpage><lpage>S37</lpage><permissions><copyright-statement>Copyright &#x000a9; 1994 Hindawi Publishing Corporation.</copyright-statement><copyright-year>1994</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract>
		<p>To compare the effectiveness of cromolyn sodium (CS)
(10 mg) and nedocromil sodium (NS) (4 mg) administered
by a metered dose inhaler (MDI) with a spacer
device in preventing exercise-induced asthma (EIA), eight
asthmatic children with EIA were studied in a
randomized double-blind, cross-over, placebo-controlled
study, CS and NS provided significant, comparable protection
from EIA and both were better than placebo. We
conclude that CS and NS administered by a pressurized
aerosol with a spacer device provide equal protection
against EIA in children.</p>
	</abstract></article-meta></front></article>


